Genmab — Februar 2021
-
MS Society Releases Guidance on DMT Dosing Modifications for COVID-19 Vaccination https://www.ajmc.com/view/ms-society-releases-guidance-on-dmt-dosing-modifications-for-covid-19-vaccination
-
for patients taking Ocrevus or Rituxan, the guidance recommends waiting to receive the first dose of the vaccine at least 12 weeks after their last treatment dose and resuming DMT treatment 4 weeks after the second dose.
For treatment with Kesimpta, the guidance suggests getting the vaccine 4 weeks after their last DMT injection and resuming Kesimpta at least 4 weeks after the second vaccine injection.
-
Jeg havde egentlig opfattelse af at Genmabs regnskab først var annonceret til i aften , men det er vist først på onsdag ,, er det blevet ændret? eller ?
-
God morgen.
-
Laks, Genmab og raketter. Lyt med i morgen på til Millionærklubben kl. 9-10. Jeg er morgentestet for corona og i studiet hos værten Pernille Enggaard og Lau Svendsen. Michael Friss er med på telefonen.
-
God morgen.
-
@Doublo 15:40, hvad mener du "resten over en årrække"? Mener du upfront payment på 750 mUSD bliver fordelt over en årrække?
-
Så Genmab indregner kun 90 % som omsætning i regnskabsåret 2020? Bliver de resterende 10 % indregnet som en forudbetaling?
-
AbbVie to pay Genmab an upfront payment of USD 750 million with total potential milestone payments of up to USD 3.15 billion
-
Jeg tænker, at vi ser de 750m indregnet med det samme
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind